Fernando Garces
Biotech Founder (Stealth) | Advisor
- Role
- Advisory Board at Abilita Therapeutics, Inc
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
About Fernando Garces
Founder (Stealth)| CEO, BioGlyph | Former Director, Protein Therapeutics at Gilead | Ex-AmgenFernando Garces, PhD, is a biotech founder and operator with deep experience building protein engineering capabilities that translate advanced science into therapeutic and platform outcomes. He is currently a founder in stealth developing AI-native approaches for biologics, and is active as an investor and advisor to companies at the intersection of computation and life sciences.Fernando is the co-founder of BioGlyph, where he previously served as CEO and CSO, building the company’s scientific vision, platform strategy, and early team. He remains a shareholder but is no longer operationally involved.Prior to BioGlyph, Fernando was Director of Protein Therapeutics at Gilead, where he founded and led the Next Generation Biologics Engineering organization, expanding capabilities across virology, oncology, and inflammation. Before Gilead, he spent nearly six years at Amgen, rising from Scientist to Principal Scientist while establishing industry-leading workflows in multispecific antibody engineering and advancing programs in cardiovascular disease and oncology.Fernando has also held leadership roles spanning platform innovation and strategy, including Director of Biotechnology and Innovation at BioMap, and serves on the Advisory Board of Abilita Therapeutics.He completed postdoctoral training at The Scripps Research Institute in the laboratory of Ian Wilson, focusing on structural immunology and antibody–antigen recognition, following earlier research at the Institute of Cancer Research in London on DNA repair and target discovery. He earned his PhD from the University of Barcelona through a competitive international fellowship and received the Scripps CHAVI-ID Young Investigator Award for contributions toward HIV vaccine development.
Experience
Advisory Board
Aug 2023 — Present
Education
Portuguese Catholic University
Bachelor of Science (BSc), Microbilogy
1998 — 2002
The Institute of Cancer Research
Post-Doctoral, DNA Repair Enzymes
2009 — 2012
Scripps Research
Post-Doctoral fellow, HIV Vaccine Design
2012 — 2016
Universitat de Barcelona
Ph.D., Biotechnology
2004 — 2008
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.